Biogen Idec (NQ: BIIB )
227.41
+2.39
(+1.06%)
Streaming Delayed Price
Updated: 11:21 AM EDT, Jul 17, 2024
Add to My Watchlist
All News about Biogen Idec
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/743836/person-being-comforted-during-therapy.jpg)
![](https://g.foolcdn.com/editorial/images/742968/a-couple-smiling-and-talking-with-an-advisor.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Looking Into Biogen's Recent Short Interest
August 08, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/743149/depression.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Biogen Unusual Options Activity For August 02
August 02, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/742615/patient-talking-with-a-physician.jpg)
![](https://www.investors.com/wp-content/uploads/2018/04/stock-Eli-Lilly-01-company.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/08/08/draftkings_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/07/sage_0.png?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2023/august/mmc/mmc-stats-aug7.png?sfvrsn=22e7a906_2)
![](https://cdn.benzinga.com/files/images/story/2023/08/07/axsm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/07/pypl.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-sagetherapeutics-02-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/08/07/sage.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230804482500/en/1860268/5/Biogen_Logo_Standard.jpg)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600.jpg)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
![](https://g.foolcdn.com/editorial/images/741916/gettyimages-1135625573.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Spanish,Bull,Running,In,The,Bullring,With,Big,Horns,On_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/741569/businessmen-and-doctors-working-on-touchpad-in-a-hospital.jpg)
![](https://g.foolcdn.com/editorial/images/741915/man-bun-investor-getty.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/drug_stocks1600.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.